Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections.
about
Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence.Cortical thickness and neurocognition in adolescent marijuana and alcohol users following 28 days of monitored abstinence.Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects.In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.Can physical exercise or food deprivation cause release of fat-stored cannabinoids?Current knowledge on cannabinoids in oral fluid.A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.Craving is associated with amygdala volumes in adolescent marijuana users during abstinenceWhite matter integrity, substance use, and risk taking in adolescenceNeural correlates of verbal learning in adolescent alcohol and marijuana usersCortical thickness in adolescent marijuana and alcohol users: A three-year prospective study from adolescence to young adulthood.Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: A three-year longitudinal studySimultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis usersPrimary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials.Longitudinal changes in white matter integrity among adolescent substance users.Cannabis in sport: anti-doping perspective.Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management.Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds.Bioanalysis of urine samples after manipulation by oxidizing chemicals: technical considerations.Detection Times of Carboxylic Acid Metabolites of the Synthetic Cannabinoids JWH-018 and JWH-073 in Human Urine.A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users.Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users.Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.
P2860
Q34103295-1EE30CF3-652E-4C8E-8AAF-5D4D146BA3A0Q34167970-FF924B6E-30D0-4648-B200-05D0FCBF40D3Q34248191-6E7E67EB-0D4D-4079-BC29-4FC8FAC64F3BQ34655618-95135C12-59A4-4879-8048-E124E1B744EBQ34730736-E5A0E315-E2C5-4E8C-B9EC-0BF1CF4DD8D8Q35940339-782A9135-2740-4415-9E47-DF707A6B396EQ35982249-209635CC-F47B-45ED-BDE7-007765B48BA5Q36054658-98A307E5-E615-40CE-969C-5825BEC22567Q36157382-27D69672-4953-4C06-885D-9D1677BEBEADQ36176900-EC917FFE-5764-4353-8D4B-BA45578B2D62Q36218320-7ECE8027-489D-42BC-912A-67586DA34B81Q36249140-2E262F04-F2DB-40B3-8135-C6D7623A84F7Q36288355-1B8718C2-7482-49FF-8137-D6EFCAC20D4FQ36288375-1EC8EC43-D219-4E02-82AC-845529AF71CCQ36433724-8C55133A-CB7A-4671-A734-FD8CBB86B45AQ36510797-CD202DF3-F9D2-4601-8EB4-36F7E3B326A1Q36542430-6428B0F0-1B2C-4968-BC0D-C19D2D107961Q37029485-E8C21EEE-6A0E-421F-A38B-411948326C49Q38154663-0D3E08EF-193B-4D5D-B172-098EB8B6F8E2Q38785676-45C46114-E649-4B5B-9C6D-F1FA89225EC7Q39156457-9A1646DA-731F-45D7-89FC-B5B0D7C7FADFQ41303209-F8E0B6FA-E06C-48F7-A160-DA07D42A4BB9Q41640325-7AF4D957-2FB0-4213-A982-0151695D76C2Q45965623-54FF0E8D-5826-4C3E-A1BE-1BB419134681Q47294789-629E14EC-E708-47BD-BEE7-E492D907264CQ47963315-29B895D0-9176-42B8-A806-48D4F40056D9
P2860
Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identifying new cannabis use w ...... between specimen collections.
@ast
Identifying new cannabis use w ...... between specimen collections.
@en
type
label
Identifying new cannabis use w ...... between specimen collections.
@ast
Identifying new cannabis use w ...... between specimen collections.
@en
prefLabel
Identifying new cannabis use w ...... between specimen collections.
@ast
Identifying new cannabis use w ...... between specimen collections.
@en
P2860
P356
P1476
Identifying new cannabis use w ...... between specimen collections.
@en
P2093
Allan J Barnes
Michael L Smith
P2860
P304
P356
10.1093/JAT/33.4.185
P577
2009-05-01T00:00:00Z